@entity453 is now uniformly treated with coronary artery bypass grafting (CABG). However, some @entity1 with @entity453 do not receive CABG because of high operative risks. The advent of stent implantation has permitted a non-operative improvement in myocardial blood flow in many @entity1 with single- and @entity453 . However, the outcomes of stent implantation for unprotected @entity453 are still unclear. Stent implantation was performed for unprotected @entity453 in 13 @entity1 ; eight @entity1 had high operative risk and five @entity1 had refused CABG. The primary success rate was 100% (13/13 @entity1 ). One @entity1 (8%) developed a non-Q-wave @entity583 after LMCA stenting. Repeat angiography was obtained in five @entity1 (38%) with recurrent angina, and three @entity1 (23%) received repeated percutaneous transluminal coronary angioplasty (PTCA) for LMCA restenosis. In the follow-up period of 18+/-3 months, 12 @entity1 (92%) remained in satisfactory condition with no further need for surgical intervention. One @entity1 (8%) ultimately required CABG, and she died after CABG at 3 months after LMCA stenting. In conclusion, although CABG remains the standard treatment for @entity453 , the present study demonstrates that stent implantation is a safe and clinically beneficial revascularization procedure for unprotected @entity453 in @entity1 who have high operative risk as well as those who refuse CABG.

Immediate and long-term outcomes of stent implantation for unprotected left main XXXX .

@entity1 :: ('9606', 'Species') :: ['patients', 'patient'] @entity453 :: ('MESH:D003324', 'Disease') :: ['multi-vessel coronary artery disease', 'Left main coronary artery (LMCA) disease', 'LMCA disease'] @entity583 :: ('MESH:D009203', 'Disease') :: ['myocardial infarction']
@entity453 :: (MESH:D003324,Disease) :: ['coronary artery disease']
